Dillione Janet 4
4 · CorMedix Inc. · Filed Dec 11, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Dillione Janet
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$9.55/sh+19,000$181,450→ 67,473 total - Exercise/Conversion
Common Stock
2025-12-09$5.63/sh+15,000$84,450→ 82,473 total - Sale
Common Stock
2025-12-09$12.00/sh−34,000$408,000→ 48,473 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-09−19,000→ 0 totalExercise: $9.55Exp: 2026-02-21→ Common Stock (19,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-09−15,000→ 0 totalExercise: $5.63Exp: 2030-02-25→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected
- [F2]These options were granted on 02/21/2016. These options are fully vested.
- [F3]These options were granted on 02/25/2020. These options are fully vested.